Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Crispr Therapeutics Ag (CRSP)  
$51.17 2.38 (4.44%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 70,650,000
Market Cap: 3.62(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $38.62 - $89.12
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 89,721 159,721 184,721 409,721
Total Sell Value $6,558,882 $10,834,513 $12,456,407 $25,314,056
Total People Sold 3 3 3 3
Total Sell Transactions 10 12 13 22
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 483
  Page 2 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kulkarni Samarth Chief Executive Officer   •       •      –    2023-05-30 4 AS $63.61 $1,621,894 D/D (25,000) 387,377 -33%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2023-05-30 4 OE $19.12 $478,000 D/D 25,000 412,377     -
   Morrow Phuong Khanh Chief Medical Officer   •       –      –    2023-05-24 4 D $65.91 $166,555 D/D (2,527) 4,411     -
   Morrow Phuong Khanh Chief Medical Officer   •       –      –    2023-05-23 4 OE $0.00 $0 D/D 6,938 6,938     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2023-04-25 4 AS $50.50 $1,266,638 D/D (25,000) 387,377 2%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2023-04-25 4 OE $19.12 $478,000 D/D 25,000 412,377     -
   Kasinger James R. General Counsel and Secretary   •       –      –    2023-03-13 4 D $43.22 $99,622 D/D (2,305) 54,844     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2023-03-13 4 D $43.22 $408,170 D/D (9,444) 387,377     -
   Kasinger James R. General Counsel and Secretary   •       –      –    2023-03-11 4 OE $0.00 $0 D/D 2,250 55,866     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2023-03-11 4 OE $0.00 $0 D/D 9,000 391,463     -
   Kasinger James R. General Counsel and Secretary   •       –      –    2023-03-10 4 OE $0.00 $0 D/D 2,833 54,899     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2023-03-10 4 OE $0.00 $0 D/D 11,833 387,821     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2023-02-27 4 AS $47.71 $1,206,243 D/D (25,000) 375,988 11%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2023-02-27 4 OE $19.12 $478,000 D/D 25,000 400,988     -
   Smith Brendan Chief Financial Officer   •       –      –    2023-02-21 4 D $48.26 $67,178 D/D (1,392) 5,072     -
   Kasinger James R. General Counsel and Secretary   •       –      –    2023-02-21 4 D $48.26 $94,107 D/D (1,950) 52,066     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2023-02-21 4 D $48.26 $307,561 D/D (6,373) 375,988     -
   Smith Brendan Chief Financial Officer   •       –      –    2023-02-18 4 OE $0.00 $0 D/D 3,825 6,464     -
   Kasinger James R. General Counsel and Secretary   •       –      –    2023-02-18 4 OE $0.00 $0 D/D 3,825 54,016     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2023-02-18 4 OE $0.00 $0 D/D 13,250 382,361     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2023-01-27 4 AS $50.60 $1,286,798 D/D (25,000) 369,111 19%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2023-01-27 4 OE $19.12 $478,000 D/D 25,000 394,111     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2022-12-28 4 AS $40.81 $1,023,290 D/D (25,000) 369,111 62%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2022-12-28 4 OE $19.12 $478,000 D/D 25,000 394,111     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2022-12-06 4 OE $1.81 $105,402 D/D 58,233 369,111     -
  483 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us